Pfizer seals $10 billion deal for Metsera as Novo Nordisk exits race - Reuters
AI Summary1 min read
TL;DR
Metsera has accepted Pfizer's $10 billion bid in an ongoing M&A battle, with the board reaffirming support amid challenges from Novo Nordisk.
- Pfizer seals $10 billion deal for Metsera as Novo Nordisk exits race Reuters
- Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits CNBC
- Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition Fox Business
- Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal The New York Times
- Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal Seeking Alpha